Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (876) Arrow Down
Filter Results: (876) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (876)
    • People  (1)
    • News  (139)
    • Research  (582)
    • Events  (1)
    • Multimedia  (7)
  • Faculty Publications  (330)

Show Results For

  • All HBS Web  (876)
    • People  (1)
    • News  (139)
    • Research  (582)
    • Events  (1)
    • Multimedia  (7)
  • Faculty Publications  (330)
← Page 17 of 876 Results →
  • August 21, 2018
  • Article

Patient–Physician Gender Concordance and Increased Mortality Among Female Heart Attack Patients

By: Brad Greenwood, Seth Carnahan and Laura Huang
We examine patient gender disparities in survival rates following acute myocardial infarctions (i.e., heart attacks) based on the gender of the treating physician. Using a census of heart attack patients admitted to Florida hospitals between 1991 and 2010, we find... View Details
Keywords: Health Disorders; Health Care and Treatment; Gender; Outcome or Result
Citation
Find at Harvard
Related
Greenwood, Brad, Seth Carnahan, and Laura Huang. "Patient–Physician Gender Concordance and Increased Mortality Among Female Heart Attack Patients." Proceedings of the National Academy of Sciences 115, no. 34 (August 21, 2018).
  • 31 Jul 2018
  • First Look

New Research and Ideas, July 31, 2018

forthcoming Journal of Medical Internet Research Reimagining Health Data Exchange: An Application Programming Interface-Enabled Roadmap for India By: Balsari, Satchit, Alexander Fortenko MD, MPH, Joaquin A. Blaya PhD, Adrian Gropper MD,... View Details
Keywords: Dina Gerdeman
  • 11 Jun 2019
  • Working Paper Summaries

Throwing the Baby Out with the Drinking Water: Unintended Consequences of Arsenic Mitigation Efforts in Bangladesh

Keywords: by Nina Buchmann, Erica Field, Rachel Glennerster, and Reshmaan Hussam
  • August 2008 (Revised September 2008)
  • Supplement

The Flaxil Label (C): Debrief and Endnotes

This case focuses on the 2001 negotiation between Mytex Pharmaceuticals and the U.S. Food and Drug Administration (FDA). The outcome of the negotiation would determine the new label for Mytex's blockbuster drug for arthritis, Flaxil. The negotiation is quite... View Details
Keywords: Safety; Value Creation; Negotiation; Health Care and Treatment; Sales; Pharmaceutical Industry
Citation
Purchase
Related
Barron, Greg M. "The Flaxil Label (C): Debrief and Endnotes." Harvard Business School Supplement 909-003, August 2008. (Revised September 2008.)
  • 19 Nov 2013
  • News

The Hidden Benefits of Keeping Teams Intact

  • Web

Faculty & Research

an early-withdrawal penalty of 1 . When households have heterogeneous present bias, the social optimum is well approximated by a two-account system: (i) an account that is completely liquid and (ii) an account that is completely illiquid until retirement. View Details
  • 02 Aug 2021
  • Blog Post

ALUMNI WORK TO REVERSE BIAS THROUGH PHILANTHROPY

Thought, one of the organizations that has received a grant from the New Commonwealth Racial Equity and Social Justice Fund. Photo by Noelia Castillo/Elevated Thought The high-profile deaths last year of Ahmaud Arbery, Breonna Taylor, Tony McDade, and George Floyd were... View Details
  • September 2017
  • Article

Time-Driven Activity-Based Costing to Estimate Cost of Care at Multidisciplinary Aerodigestive Centers

By: Robert S. Kaplan, Jordan A. Garcia, Bipin Mistry, Stephen Hardy, Mary Shannon Fracchia, Cheryl Hersh, Carissa Wentland, Joseph Vadakekalam and Christopher J. Hartnick
Time-driven activity-based costing was used to estimate the cost of care for patients with laryngeal cleft seen between 2008 and 2013 at the Massachusetts Eye and Ear Infirmary Pediatric Aerodigestive Center. Retrospective chart review was performed to identify clinic... View Details
Keywords: Time-Driven Activity-Based Costing; Activity Based Costing and Management; Health Care and Treatment
Citation
Find at Harvard
Purchase
Related
Kaplan, Robert S., Jordan A. Garcia, Bipin Mistry, Stephen Hardy, Mary Shannon Fracchia, Cheryl Hersh, Carissa Wentland, Joseph Vadakekalam, and Christopher J. Hartnick. "Time-Driven Activity-Based Costing to Estimate Cost of Care at Multidisciplinary Aerodigestive Centers." The Laryngoscope 127, no. 9 (September 2017).
  • 27 Sep 2011
  • First Look

First Look: September 27

set of insights regarding how networks of interorganizational relationships shape the behaviors and outcomes of corporate actors. This research has provided compelling evidence that the concrete patterns of relationships in which... View Details
Keywords: Sean Silverthorne
  • 27 Aug 2013
  • First Look

First Look: August 27

outcomes while controlling for the endogenous matching of projects and organizational forms. Solo firm leases are less profitable than alliance leases because alliance members combine their information and expertise. Publisher's link:... View Details
Keywords: Sean Silverthorne
  • November–December 2014
  • Article

Using Time-Driven Activity-Based Costing to Identify Value-Improvement Opportunities in Healthcare

By: Robert S. Kaplan, Mary L. Witkowski, Megan Abbott, Alexis Guzman, Laurence Higgins, John Meara, Erin Padden, Apurva Shah, Peter Waters, Marco Weidemeier, Samuel Wertheimer and Thomas W. Feeley
As healthcare providers cope with pricing pressures and increased accountability for performance, they should be rededicating themselves to improving the value they deliver to their patients: better outcomes and lower costs. Time-driven activity-based costing offers... View Details
Keywords: Value Creation; Activity Based Costing and Management; Health Care and Treatment; Health Industry; United States; Europe
Citation
Find at Harvard
Related
Kaplan, Robert S., Mary L. Witkowski, Megan Abbott, Alexis Guzman, Laurence Higgins, John Meara, Erin Padden, Apurva Shah, Peter Waters, Marco Weidemeier, Samuel Wertheimer, and Thomas W. Feeley. "Using Time-Driven Activity-Based Costing to Identify Value-Improvement Opportunities in Healthcare." Journal of Healthcare Management 59, no. 6 (November–December 2014): 399–413.
  • 2019
  • White Paper

Impact-Weighted Financial Accounts: The Missing Piece for an Impact Economy

By: George Serafeim, T. Robert Zochowski and Jennifer Downing
Reimagining capitalism is an imperative. We need to create a more inclusive and sustainable form of capitalism that works for every person and the planet. Massive environmental damage, growing income and wealth disparity, stress, and depression within developed... View Details
Keywords: Impact-Weighted Accounts; IWAI; Background; Economic Systems; Economy; Corporate Social Responsibility and Impact; Measurement and Metrics; Financial Statements
Citation
Read Now
Related
Serafeim, George, T. Robert Zochowski, and Jennifer Downing. "Impact-Weighted Financial Accounts: The Missing Piece for an Impact Economy." White Paper, Harvard Business School, Boston, MA, September 2019.
  • 28 Nov 2011
  • Research & Ideas

Rethinking the Fairness of Organ Transplants

system to provide good matches so patients survive longer, but with fairness. By contrast, rather than designing a policy and then looking at what the outcomes are, Trichakis and his coauthors allow policymakers to start with desired... View Details
Keywords: by Dennis Fisher; Health
  • Article

Use of Connected Digital Products in Clinical Research Following the COVID-19 Pandemic: A Comprehensive Analysis of Clinical Trials

By: Caroline Marra, William J. Gordon and Ariel Dora Stern
Objectives: In an effort to mitigate COVID-19 related challenges for clinical research, the U.S. Food and Drug Administration (FDA) issued new guidance for the conduct of ‘virtual’ clinical trials in late March 2020. This study documents trends in the use of... View Details
Keywords: Connected Digital Products; Telehealth; Remote Monitoring; Health Testing and Trials; Research; Governing Rules, Regulations, and Reforms; Information Technology
Citation
Read Now
Related
Marra, Caroline, William J. Gordon, and Ariel Dora Stern. "Use of Connected Digital Products in Clinical Research Following the COVID-19 Pandemic: A Comprehensive Analysis of Clinical Trials." BMJ Open 11, no. 6 (2021).
  • 2018
  • Working Paper

How Scheduling Can Bias Quality Assessment: Evidence from Food Safety Inspections

By: Maria Ibanez and Michael W. Toffel
Many production processes are subject to inspection to ensure they meet quality, safety, and environmental standards imposed by companies and regulators. Inspection accuracy is critical to inspections being a useful input to assessing risks, allocating quality... View Details
Keywords: Assessment; Bias; Inspection; Scheduling; Econometric Analysis; Empirical Research; Regulation; Health; Food; Safety; Quality; Performance Consistency; Performance Evaluation; Food and Beverage Industry; Service Industry
Citation
SSRN
Read Now
Related
Ibanez, Maria, and Michael W. Toffel. "How Scheduling Can Bias Quality Assessment: Evidence from Food Safety Inspections." Harvard Business School Working Paper, No. 17-090, April 2017. (Revised October 2018. Formerly titled "Assessing the Quality of Quality Assessment: The Role of Scheduling". Featured in Forbes, Food Safety Magazine, and Food Safety News.)
  • 18 Oct 2021
  • Blog Post

Embracing Activism for Social Change

Co-Response Partnership, a pilot program implemented with the county’s mental health authority, Detroit Wayne Integrated Health Network (DWIHN), designed to create better View Details
  • 20 Nov 2018
  • First Look

New Research and Ideas, November 20, 2018

Outcome measures top the list, with 60% of respondents saying they are extremely important. This survey suggests that many in health care see value-based reimbursement as a real solution to the nation’s... View Details
Keywords: Dina Gerdeman
  • July–September 2023
  • Article

A Systematic Review of Respect Between Acute Care Nurses and Physicians

By: Derrick P. Bransby, Anna T. Mayo, Matthew A. Cronin, Katie Park and Christina Yuan
Background: Interprofessional collaboration between nurses and physicians has become an essential part of patient care, which, when lacking, can lead to well-known challenges. One possible explanation for ineffective nurse–physician collaboration is a lack of... View Details
Keywords: Relationships; Status and Position; Cooperation; Attitudes; Behavior; Outcome or Result; Health Industry
Citation
Purchase
Related
Bransby, Derrick P., Anna T. Mayo, Matthew A. Cronin, Katie Park, and Christina Yuan. "A Systematic Review of Respect Between Acute Care Nurses and Physicians." Health Care Management Review 48, no. 3 (July–September 2023): 237–248.
  • May 21, 2020
  • Editorial

Primary Care Is Hurting: Why Aren't Private Insurers Pitching In?

By: Leemore S. Dafny and J. Michael McWilliams
Primary care clinicians are the front line for patients with suspected infection. We rely on them to diagnose, triage, and manage patients with potential or confirmed COVID infections. They are also responsible for keeping non-COVID medical conditions under control... View Details
Keywords: COVID-19; Primary Care; Health Pandemics; Health Care and Treatment; Financial Condition; Insurance
Citation
Read Now
Related
Dafny, Leemore S., and J. Michael McWilliams. "Primary Care Is Hurting: Why Aren't Private Insurers Pitching In?" Health Affairs Blog (May 21, 2020).
  • August 2008 (Revised September 2008)
  • Case

The Flaxil Label (A)

This case focuses on the 2001 negotiation between Mytex Pharmaceuticals and the U.S. Food and Drug Administration (FDA). The outcome of the negotiation would determine the new label for Mytex's blockbuster drug for arthritis, Flaxil. The negotiation is quite... View Details
Keywords: Governing Rules, Regulations, and Reforms; Health Disorders; Product Launch; Negotiation Process; Business and Government Relations; Safety; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Barron, Greg M. "The Flaxil Label (A)." Harvard Business School Case 909-001, August 2008. (Revised September 2008.)
  • ←
  • 17
  • 18
  • …
  • 43
  • 44
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.